How Do Regulatory Barriers Impact Drug Development?
The drug development process for cancer therapies is often lengthy and complex, involving several phases of clinical trials. Regulatory agencies like the FDA in the United States and the European Medicines Agency in Europe impose stringent guidelines to ensure the safety and efficacy of new drugs. While these guidelines are crucial for patient safety, they can also delay the time it takes for new treatments to reach the market.
